GEMMs as preclinical models for testing pancreatic cancer therapies
GEMMs as preclinical models for testing pancreatic cancer therapies
About this item
Full title
Author / Creator
Publisher
England: The Company of Biologists Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: The Company of Biologists Ltd
Subjects
More information
Scope and Contents
Contents
Pancreatic ductal adenocarcinoma is the most common form of pancreatic tumour, with a very limited survival rate and currently no available disease-modifying treatments. Despite recent advances in the production of genetically engineered mouse models (GEMMs), the development of new therapies for pancreatic cancer is still hampered by a lack of reli...
Alternative Titles
Full title
GEMMs as preclinical models for testing pancreatic cancer therapies
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_5e6bdc5d49834fd9899584727434905b
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5e6bdc5d49834fd9899584727434905b
Other Identifiers
ISSN
1754-8403,1754-8411
E-ISSN
1754-8411,1754-8403
DOI
10.1242/dmm.021055
